E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/26/2008 in the Prospect News PIPE Daily.

New Issue: Lombard orchestrates £1.6 million placement of convertibles

By Devika Patel

Knoxville, Tenn., Sept. 26 - Lombard Medical Technologies plc said it hopes to raise £1.6 million in a private placement of convertible loan notes.

The notes will be unsecured and will yield a gross coupon of 1% above the average annual base rate of the Bank of England.

The company may force conversion at any time.

Insiders will buy a total of £75,000 of the notes.

The placing has been underwritten by Nomura Code Securities Ltd.

Proceeds will be used to complete the company's ongoing long-term financing discussions as well as progress certain key near-term objectives.

The company also said that the proceeds from the deal along with existing cash resources will allow Lombard to trade into January 2009. If the board is unable to secure additional sources of funding, the company will have insufficient resources to trade beyond that date.

Lombard is a medical device company based in London.

Issuer:Lombard Medical Technologies plc
Issue:Convertible unsecured loan notes
Amount:£1.6 million
Coupon:Base plus 1%
Price:Par
Yield:Base plus 1%
Underwriter:Nomura Code Securities Ltd.
Pricing date:Sept. 26
Stock symbol:London: LMT
Stock price:2.15p at close Sept. 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.